Related Experiment Video
Updated: Sep 25, 2025
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn
Kirat Chand1, Rachel Nano2, Julie Wixey1
1UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
Insights
Fetal growth restriction (FGR) can cause lifelong neurodevelopmental issues. Stem cell therapy shows promise for protecting FGR newborns from brain damage, offering hope for future treatments.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Perinatal Medicine
Background:
- Fetal growth restriction (FGR) impairs fetal development due to placental insufficiency.
- FGR newborns face high risks of adverse neurodevelopmental outcomes, including cerebral palsy and learning difficulties.
- Current treatments lack neuroprotective capabilities for FGR neonates.
Purpose of the Study:
- To review advancements in stem cell therapy for neurological diseases.
- To explore the potential application of stem cell therapy for FGR newborns.
- To highlight preclinical studies and outline steps toward clinical trials.
Main Methods:
- Review of existing literature on stem cell therapy in neurological disorders.
- Analysis of preclinical research in FGR animal models.
- Identification of key research gaps and future clinical trial requirements.
Main Results:
- Stem cell therapies demonstrate potential for tissue repair and regeneration in neurological contexts.
- Preclinical studies in FGR models indicate promising neuroprotective effects.
- Chronic inflammation and vascular disruption in FGR brains are key targets for intervention.
Conclusions:
- Stem cell therapy represents a promising avenue for neuroprotection in FGR neonates.
- Further preclinical validation and research are necessary before clinical application.
- Targeted stem cell interventions could mitigate long-term neurological disability in FGR infants.
Abstract:
Fetal growth restriction (FGR) occurs when a fetus is unable to grow normally due to inadequate nutrient and oxygen supply from the placenta. Children born with FGR are at high risk of lifelong adverse neurodevelopmental outcomes, such as cerebral palsy, behavioral issues, and learning and attention difficulties. Unfortunately, there is no treatment to protect the FGR newborn from these adverse neurological outcomes. Chronic inflammation and vascular disruption are prevalent in the brains of FGR neonates and therefore targeted treatments may be key to neuroprotection. Tissue repair and regeneration via stem cell therapies have emerged as a potential clinical intervention for FGR babies at risk for neurological impairment and long-term disability. This review discusses the advancement of research into stem cell therapy for treating neurological diseases and how this may be extended for use in the FGR newborn. Leading preclinical studies using stem cell therapies in FGR animal models will be highlighted and the near-term steps that need to be taken for the development of future clinical trials.
More Related Videos
09:37A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue
Published on: June 15, 2014
11:27Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain
Published on: November 18, 2013
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...